Published Date: 23 Aug 2024
Alternate criteria based on years of smoking has higher sensitivity and specificity, study says
Read Full NewsRifabutin-based triple regimen is noninferior to classical bismuth quadruple regimen as rescue treatment for Helicobacter pylori infection.
Hematology advanced nurse practitioners receive high satisfaction scores from clinicians and patients, although room for improvement remains regarding role clarity, a study reports.
Digital FDG PET/CT can pick up cranial giant cell arteritis that may be missed on ultrasound because of a lack of trunk large-vessel involvement.
Urinary tract infection during pregnancy is linked to an increased risk for preterm birth, with the risk being highest in the first week of diagnosis and particularly before 28 weeks of gestation.
A unique six-decade study shows that higher prenatal and early postnatal lead exposure is tied to cognitive performance in older adulthood.
NICE recommends epcoritamab for relapsed follicular lymphoma, offering a new option after multiple lines of therapy.
Rates of the side effect appear to be increasing, but it’s not yet clear why.
1.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
2.
Researchers Challenge USPSTF's Lung Cancer Screening Criteria
3.
Indoor hydroponic gardening can improve mental health and quality of life for cancer patients
4.
Using AI, one can find cancer risk factors.
5.
A novel test shows promise for finding cervical adenocarcinoma, which is difficult to find.
1.
Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care
2.
Everything You Need to Know About CA 19-9 and Cancer Diagnosis
3.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
4.
From Birthmarks to Tumors: The Science Behind Infantile Hemangioma
5.
AI Revolutionizes Immunotherapy: Unveiling Biomarkers with Machine Intelligence
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
Should We Use DARA Up Front As First-Line Therapy in MM?
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation